Term Name: | cobimetinib |
---|---|
Synonyms: | [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone, cobimetinib, GDC 0973, GDC-0973, GDC0973, RG 7420, RG7420, Xl 518, Xl-518, XL518 |
Definition: | A member of the class of N-acylazetidines obtained by selective formal condensation of the carboxy group of 3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid with the secondary amino group from the azetidine ring of 3-[(2S)-piperidin-2-yl]azetidin-3-ol. An inhibitor of mitogen-activated protein kinase that is used (as its fumarate salt) in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma. |
Ontology: | ChEBI [CHEBI:90851] ( EBI ) |